-
Pfizer to submit NDA for palbociclib
NEW YORK — Pfizer announced plans to submit a new drug application with the Food and Drug Administration for palbociclib (combined with letrozole). The drug is used for the first-line systemic treatment of post-menopausal women with advanced or metastatic breast cancer.
The company said it plans to submit the NDA early in third quarter 2014. The decision to file was based on discussions with the FDA surrounding the final results of a randomized, Phase 2 trial called PALOMA-1. -
Nordic Naturals intros Vitamin C Gummies
WATSONVILLE, Calif. — Nordic Naturals introduced Vitamin C Gummies, providing 250 mg of vitamin C. With a tart tangerine flavor, Vitamin C Gummies are chewable gummy slices for kids 4 years and older.
The product is pectin-based, and free of gelatin, artificial colors, artificial flavors, preservatives and allergens, including gluten, milk, eggs, tree nuts, peanuts and soy.